Bull&Bear | Veea Surges 133% on Strategic Partnership, XCharge Soars with Nasdaq Listing

Generated by AI AgentAinvest Movers Radar
Wednesday, Sep 18, 2024 6:00 pm ET1min read
APLT--
VEEA--

Advancing Stocks:

Veea (VEEA) surged 133.33%. Veea has announced a strategic partnership with Crowdkeep to integrate their respective technologies into a custom solution aimed at tracking assets, personnel, and environmental conditions for various use cases.

Applied Therapeutics (APLT) rose 68.82%. The stock price increased following an update on the review of a new drug application for the treatment of classic galactosemia.

XCharge (XCH) increased 65.50%, marking a three-day gain of 132.53%. XCharge, part of the Asia Green Fund's portfolio, successfully listed on Nasdaq.

Intuitive Machines (LUNR) climbed 38.33%. The company secured a significant contract worth nearly $5 billion.

Gallius Talent (GLXG) rose 32.03%. The company successfully debuted on the US stock market, with its first-day trading price exceeding the initial public offering price.

Declining Stocks:

Children's Place (PLCE) dropped 12.99%. Despite reaching a six-month high, short-sellers are putting pressure on the stock.

Nano Nuclear (NNE) fell 11.54%, experiencing a three-day decline of 28.04%. Nano Nuclear signed an agreement with GNS for design work aimed at optimizing its advanced nuclear fuel transportation technology.

ESSA Pharma (EPIX) declined 10.64%, experiencing a two-day drop of 13.57%. Data from ESSA Pharma's prostate cancer therapy, Masofaniten, was presented at the 2024 ESMO conference, showing sustained PSA reduction.

FreightCar America (RAIL) decreased 10.05%. There have been recent insider sales of FreightCar America stock.

Cerus (CERS) fell 9.64%, registering a three-day decline of 14.01%. Institutional investors hold 65% of Cerus's equity, indicating a high level of risk.

Knowing stock market today at a glance

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet